APA (7th ed.) Citation

C, O., JE, H., H, Y., H, P., SY, K., JK, L., & HJ, I. (2025). pH-responsive Oral liposomal delivery of hydrogen sulfide donor GYY4137 enables colon-targeted therapy for inflammatory bowel disease. Journal of nanobiotechnology, 23(1), 712. https://doi.org/10.1186/s12951-025-03753-9

Chicago Style (17th ed.) Citation

C, Oh, Hwang JE, Yim H, Park H, Kim SY, Lee JK, and Im HJ. "PH-responsive Oral Liposomal Delivery of Hydrogen Sulfide Donor GYY4137 Enables Colon-targeted Therapy for Inflammatory Bowel Disease." Journal of Nanobiotechnology 23, no. 1 (2025): 712. https://doi.org/10.1186/s12951-025-03753-9.

MLA (9th ed.) Citation

C, Oh, et al. "PH-responsive Oral Liposomal Delivery of Hydrogen Sulfide Donor GYY4137 Enables Colon-targeted Therapy for Inflammatory Bowel Disease." Journal of Nanobiotechnology, vol. 23, no. 1, 2025, p. 712, https://doi.org/10.1186/s12951-025-03753-9.